Quince Therapeutics
QNCX
#11211
Rank
โ‚ฌ0.78 M
Marketcap
0,80ย โ‚ฌ
Share price
-2.43%
Change (1 day)
-41.92%
Change (1 year)

EPS for Quince Therapeutics (QNCX)

EPS in 2026 (TTM): -113,75ย โ‚ฌ

According to Quince Therapeutics's latest financial reports the company's current EPS (TTM) is -112,16ย โ‚ฌ. In 2019 the company made an earnings per share (EPS) of -281,86ย โ‚ฌ.

EPS history for Quince Therapeutics from 2019 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-113,75ย โ‚ฌ
2019-281,86ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,25ย โ‚ฌ-98.88%๐Ÿ‡บ๐Ÿ‡ธ USA